Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Spitzer

Showing results (311-320 of 361) with videos related to

Pageof 37
Sort By:
Blood|May 6, 2017
Phase 1 multicenter trial of brentuximab vedotin for steroid-refractory acute graft-versus-host diseaseYi-Bin Chen, Miguel-Angel Perales, Shuli Li, et al.
Transplantation|November 19, 2010
Mixed chimerism, lymphocyte recovery, and evidence for early donor-specific unresponsiveness in patients receiving combined kidney and bone marrow transplantation to induce toleranceSamuel A LoCascio, Tatsuaki Morokata, Meredith Chittenden, et al.
Pediatrics|July 1, 1997
Safety and pharmacokinetics of multiple doses of recombinant human CuZn superoxide dismutase administered intratracheally to premature neonates with respiratory distress syndromeJ M Davis, W N Rosenfeld, S E Richter, et al.
Leukemia & Lymphoma|December 3, 2011
Risk factors for development of pneumonitis after high-dose chemotherapy with cyclophosphamide, BCNU and etoposide followed by autologous stem cell transplantAndrew A Lane, Philippe Armand, Yang Feng, et al.
JAMA|November 29, 2016
Effect of Inpatient Palliative Care on Quality of Life 2 Weeks After Hematopoietic Stem Cell Transplantation: A Randomized Clinical TrialAreej El-Jawahri, Thomas LeBlanc, Harry VanDusen, et al.
Cancer|December 10, 2015
Quality of life and mood predict posttraumatic stress disorder after hematopoietic stem cell transplantationAreej R El-Jawahri, Harry B Vandusen, Lara N Traeger, et al.
Transplantation|January 28, 1999
Porcine kidney and heart transplantation in baboons undergoing a tolerance induction regimen and antibody adsorptionT Kozlowski, A Shimizu, D Lambrigts, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 12, 2015
Phase II Trial of Reduced-Intensity Busulfan/Clofarabine Conditioning with Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Acute Myeloid Leukemia, Myelodysplastic Syndromes, and Acute Lymphoid LeukemiaAreej El-Jawahri, Shuli Li, Karen K Ballen, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 8, 2011
Mechanisms of donor-specific tolerance in recipients of haploidentical combined bone marrow/kidney transplantationG Andreola, M Chittenden, J Shaffer, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 9, 2013
Busulfan dose intensity and outcomes in reduced-intensity allogeneic peripheral blood stem cell transplantation for myelodysplastic syndrome or acute myeloid leukemiaYi-Bin Chen, Erin Coughlin, Kevin F Kennedy, et al.
Pageof 37

Showing results (311-320 of 361) with videos related to

Sort By:
Pageof 37
Blood|May 6, 2017
Phase 1 multicenter trial of brentuximab vedotin for steroid-refractory acute graft-versus-host diseaseYi-Bin Chen, Miguel-Angel Perales, Shuli Li, et al.
Transplantation|November 19, 2010
Mixed chimerism, lymphocyte recovery, and evidence for early donor-specific unresponsiveness in patients receiving combined kidney and bone marrow transplantation to induce toleranceSamuel A LoCascio, Tatsuaki Morokata, Meredith Chittenden, et al.
Pediatrics|July 1, 1997
Safety and pharmacokinetics of multiple doses of recombinant human CuZn superoxide dismutase administered intratracheally to premature neonates with respiratory distress syndromeJ M Davis, W N Rosenfeld, S E Richter, et al.
Leukemia & Lymphoma|December 3, 2011
Risk factors for development of pneumonitis after high-dose chemotherapy with cyclophosphamide, BCNU and etoposide followed by autologous stem cell transplantAndrew A Lane, Philippe Armand, Yang Feng, et al.
JAMA|November 29, 2016
Effect of Inpatient Palliative Care on Quality of Life 2 Weeks After Hematopoietic Stem Cell Transplantation: A Randomized Clinical TrialAreej El-Jawahri, Thomas LeBlanc, Harry VanDusen, et al.
Cancer|December 10, 2015
Quality of life and mood predict posttraumatic stress disorder after hematopoietic stem cell transplantationAreej R El-Jawahri, Harry B Vandusen, Lara N Traeger, et al.
Transplantation|January 28, 1999
Porcine kidney and heart transplantation in baboons undergoing a tolerance induction regimen and antibody adsorptionT Kozlowski, A Shimizu, D Lambrigts, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 12, 2015
Phase II Trial of Reduced-Intensity Busulfan/Clofarabine Conditioning with Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Acute Myeloid Leukemia, Myelodysplastic Syndromes, and Acute Lymphoid LeukemiaAreej El-Jawahri, Shuli Li, Karen K Ballen, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 8, 2011
Mechanisms of donor-specific tolerance in recipients of haploidentical combined bone marrow/kidney transplantationG Andreola, M Chittenden, J Shaffer, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 9, 2013
Busulfan dose intensity and outcomes in reduced-intensity allogeneic peripheral blood stem cell transplantation for myelodysplastic syndrome or acute myeloid leukemiaYi-Bin Chen, Erin Coughlin, Kevin F Kennedy, et al.
Pageof 37